Related Experiment Video
Updated: Apr 8, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
Published on: January 20, 2023
Oncogenic acidic nuclear phosphoproteins ANP32C/D are novel clients of heat shock protein 90
Yuliia Yuzefovych1, Rainer Blasczyk1, Trevor Huyton1
1Institute for Transfusion Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany.
Abstract:
The acidic nuclear phosphoproteins (ANP32A-H) are an evolutionarily conserved family of proteins with diverse and sometimes opposing cellular functions. Here we show that the oncogenic family members ANP32C and ANP32D are associated in complexes containing the molecular chaperone Hsp90. The oncogenic ANP32C protein appears to be highly unstable with a rapid degradation (t1/2>30 min) occurring upon treatment of cells with cycloheximide. ANP32C was also found to be associated with oncogenic Hsp90 complexes by virtue of its ability to interact and be immunoprecipitated by the Hsp90 inhibitor PU-H71. Further studies treating cells with the Hsp90 inhibitors PU-H71 and 17-AAG showed atypical increased protein stability and prevention of ANP32C degradation compared to the Hsp90 client AKT. Cells overexpressing ANP32C or its mutant ANP32CY140H showed enhanced sensitivity to treatment with PU-H71 as demonstrated by CCK-8 and colony formation assays. Our results highlight that certain malignancies with ANP32C/D overexpression or mutation might be specifically targeted using Hsp90 inhibitors.
Insights
Oncogenic proteins ANP32C and ANP32D interact with Hsp90. Inhibiting Hsp90 stabilizes ANP32C, offering a potential therapeutic strategy for ANP32C/D-driven malignancies.
Area of Science:
- Molecular biology
- Oncology
- Protein biochemistry
Background:
- Acidic nuclear phosphoproteins (ANP32A-H) are conserved proteins with varied functions.
- Oncogenic members ANP32C and ANP32D play roles in cancer development.
Purpose of the Study:
- To investigate the interaction between oncogenic ANP32C/D proteins and the molecular chaperone Hsp90.
- To explore the therapeutic potential of Hsp90 inhibitors in targeting ANP32C/D-driven malignancies.
Main Methods:
- Co-immunoprecipitation assays to detect protein interactions.
- Cycloheximide chase experiments to assess protein stability.
- Cell viability and colony formation assays to evaluate drug sensitivity.
Main Results:
- ANP32C and ANP32D were found to associate with Hsp90.
- Hsp90 inhibitors (PU-H71, 17-AAG) stabilized ANP32C, preventing its degradation.
- Cells overexpressing ANP32C or its mutant showed increased sensitivity to PU-H71.
Conclusions:
- ANP32C stability is regulated by Hsp90.
- Hsp90 inhibitors represent a promising therapeutic approach for cancers with ANP32C/D alterations.
Related Concept Videos
Anaphase Promoting Complex
Abnormal Proliferation
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
Regulation of Nuclear Protein Sorting
The Intrinsic Apoptotic Pathway
Bacterial Protein Maturation

